The company, already scaling across Europe, plans to accelerate the deployment of its medication reconciliation platform in the United States
The sNDA was supported by the clinical results from cohort B of a single-arm, multi-center, pivotal study (RELIANCE study) on Carteyva in adult patients with relapsed or refractory B cell non-hodgkin lymphoma in China
It is the first approved blood test that can predict likely progression to Alzheimer's Disease up to six years in advance
The method shows the removal of seven types of PFAS – even when all of them are found in the same unit of fluid – at a level of efficiency that approaches 90%, and it does so within a few minutes
Confirmed positive phase 3 topline results in addition to Enavogliflozin monotherapy and Metformin combination therapy
PSCI, a global non-profit organization, works with its members to ensure a positive environment that can improve global healthcare supply chains
The facility is spread across 215000 sq. feet and provides super-speciality care
This policy will ensure multi-disciplinary collaboration, promote start-up culture and develop an innovation-led ecosystem at medical institutes across the country
The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers
Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR
Subscribe To Our Newsletter & Stay Updated
